Attainia’s equipment planning system adds GE Healthcare imaging equipment
Sep 11, 2012
All GE Healthcare imaging modalities have been added to Attainia’s catalog, including Computed Tomography, Magnetic Resonance Imaging, Mammography, Molecular Imaging, Nuclear Medicine, Positron Emission...
AHCA will incorporate PointRight’s rehospitalization metric into its Quality Initiative
Sep 05, 2012
PointRight combines Minimum Data Set 3.0 data and unique analytics to calculate case-mix adjusted hospital readmission rates.
OnShift unveils acuity-based staffing software
Sep 05, 2012
Staff Exact identifies staffing requirements by position and location, to the hour. The result is better resident care and labor cost management, according to the firm.
Expand electronic health record incentives to long-term care, providers insist
Sep 05, 2012
Federal health officials need to expand incentives for adopting Stage 3 Meaningful Use criteria for electronic health records to long-term care operators, a provider group demands in a new report.
Brochure explains how wound care product works
Aug 29, 2012
Hartmann USA recently unveiled a brochure that explains the benefits of using its first silver product, Sorbalgon Ag wound care dressing.
Status Solutions announces demo partnership
Aug 29, 2012
HealthDynamix and Status Solutions will host demonstrations of Status Solutions’ Communication and Access to Information Everywhere technology on Sept. 11 in Columbus, OH, and Sept. 18 in Charlotte,...
Shoe insert senses foot numbness that can precede diabetic ulcers
Aug 22, 2012
Orpyx Medical Technologies is developing a wireless shoe insert that will help people with diabetes manage peripheral nerve damage and hopefully prevent diabetic foot ulcers.
Need an MDS conversion? There’s an app for that
Aug 14, 2012
Software vendor Caradigm has developed an application that converts Minimum Data Set information to Continuity of Care Documents.
Detector helps locate bedbugs
Aug 14, 2012
The product helps long-term care operators detect bedbugs that may be lurking in facilities.
Phase III trials of Alzheimer’s drug are halted
Aug 14, 2012
The tests, for the drug bapineuzumab, are being stopped after the drug failed to hit its goals for cognition and global function.